▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.Healthcare professionals are asked to report any suspected adverse reactions to
HPRA Pharmacovigilance,
Earlsfort Terrace,
IRL – Dublin 2;
Tel: +353 1 676 4971;
Fax: +353 1 676 2517;
Website: https://www.hpra.ie/; Email: medsafety@hpra.ie.Adverse events should also be reported to Otsuka UK at opuksafety@otsuka.co.uk or by calling +353 1 695 0725.Pregnancy and pregnancy outcomes should also be reported using the same details provided above.
HPRA Pharmacovigilance,
Earlsfort Terrace,
IRL – Dublin 2;
Tel: +353 1 676 4971;
Fax: +353 1 676 2517;
Website: https://www.hpra.ie/; Email: medsafety@hpra.ie.Adverse events should also be reported to Otsuka UK at opuksafety@otsuka.co.uk or by calling +353 1 695 0725.Pregnancy and pregnancy outcomes should also be reported using the same details provided above.